{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-055002","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2023-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.742700+00:00","generated_at":"2026-06-09T09:59:55.093899+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Precision BioSciences transfers to Nasdaq Capital Market; gets 180-day grace for bid price compliance","bullets":["Transfer from Nasdaq Global Select to Nasdaq Capital Market effective Oct 26, 2023; ticker remains DTIL.","Nasdaq granted 180-day grace period until Apr 22, 2024 to regain $1.00 minimum bid price for 10 consecutive days.","Company notified Nasdaq it may effect a reverse stock split to cure the bid price deficiency.","If compliance not regained, Nasdaq will issue delisting notice; company may appeal to a Hearings Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-055002","json":"https://secwatch.observer/filing/0000950170-23-055002.json","markdown":"https://secwatch.observer/filing/0000950170-23-055002.md","text":"https://secwatch.observer/filing/0000950170-23-055002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000095017023055002/0000950170-23-055002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000095017023055002/dtil-20231024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T09:59:55.093899+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f6e557d53e0036599f54b7c98814aeef6cfb3d91","claim":"PRECISION BIOSCIENCES INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"April 24, 2023, the Company received a letter from Nasdaq indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1) because the closing bid price per share for the Company’s common stock had closed below $1.00 for the previous 30 consecutive business days (the “Minimum Bid Price Requirement”). In response, the Company filed an application to transfer the listing of its common stock from the Nasdaq Global Select Market to the Nasdaq Capital Market. As a result of the Approval, the Company has been granted an additional 180-day grace period, or until April 22, 2024, t","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017023055002/0000950170-23-055002-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}